Target intelligence / Profile preview

Ricin A chain–B chain disulfide bond

Molecular classification
Other (disulfide linkage between protein subunits)
01

Overview

The **ricin A chain–B chain disulfide bond** is a single covalent linkage that joins the enzymatically active A chain (RTA) to the cell-binding B chain (RTB) of the heterodimeric plant toxin ricin[4][5]. Upon cellular uptake, reduction of this disulfide bond in the endoplasmic reticulum is a critical step that releases the A chain into the cytosol[3][4][5]. The free A chain then catalyzes the depurination of a specific adenine residue in the 28S rRNA of eukaryotic ribosomes, halting protein synthesis and leading to cell death[1][3][4]. The disulfide bond itself is not a therapeutic target, but its cleavage is essential for ricin's mechanism of action; thus, the term "ricin disulfide bond cleavage" refers to a step in ricin toxicity and not an independent receptor, enzyme, or molecular target.

Other names
Ricin interchain disulfideRicin A-B chain disulfide bond
02

Mechanism of action

Disulfide bond reduction releases the enzymatic A chain to enter the cytosol and inhibit protein synthesis[3][4][5].

03

Biological functions

Enables activation of ricin cytotoxicity via A chain release
04

Disease associations

Infection (as a biological warfare agent)Other (cell death due to ricin exposure)
05

Safety considerations

Extreme toxicity of ricin following cell entry and A chain activation[1][3][4]

Beyond the preview

Go deeper on Ricin A chain–B chain disulfide bond.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ricin A chain–B chain disulfide bond.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call